2024 Rome, Italy

C-16 Anna Kondic
The combined use of propensity score matching and a joint tumor growth dynamics (TGD) - Overall Survival (OS) model to benchmark the efficacy of new treatments for advanced renal cell carcinoma (RCC)
Thursday 15:00-15:20